Plaque-fighting nanoparticles could help prevent heart attacks and strokes

Scientists have created a new type of nanoparticle capable of not only imaging harmful plague inside arteries using MRI but simultaneously treating it as well. The findings were announced at the National Meeting and Exposition of the American Chemical Society.

The nanoparticle is designed to mimic the functions of the body’s own high-density lipoprotein (HDL), also known as “good” HDL cholesterol, which extracts low-density lipoprotein, or "bad" cholesterol, from arterial plaques. A hydrophobic core of iron oxide makes the nanoparticle light up on MRI scans, revealing the exact location of plaque buildup.

Researchers are currently studying how well the particles locate and treat plaques in animals, with clinical trials expected to begin within two years.

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.